BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schalla MA, Stengel A. Pharmacological Modulation of Ghrelin to Induce Weight Loss: Successes and Challenges. Curr Diab Rep 2019;19. [DOI: 10.1007/s11892-019-1211-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lu X, Huang L, Huang Z, Feng D, Clark RJ, Chen C. LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of Obesity. Front Endocrinol (Lausanne) 2021;12:717544. [PMID: 34512549 DOI: 10.3389/fendo.2021.717544] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Debom GN, Rubenich DS, Braganhol E. Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes. Front Neurosci 2021;15:648476. [PMID: 35069091 DOI: 10.3389/fnins.2021.648476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tuero C, Valenti V, Rotellar F, Landecho MF, Cienfuegos JA, Frühbeck G. Revisiting the Ghrelin Changes Following Bariatric and Metabolic Surgery. Obes Surg 2020;30:2763-80. [PMID: 32323063 DOI: 10.1007/s11695-020-04601-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Schalla MA, Stengel A. LEAP2: A novel regulator of food intake and body weight? Nat Rev Gastroenterol Hepatol 2019;16:711-2. [DOI: 10.1038/s41575-019-0224-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Borgland SL. Can treatment of obesity reduce depression or vice versa? J Psychiatry Neurosci 2021;46:E313-8. [PMID: 33876735 DOI: 10.1503/jpn.210036] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Schalla MA, Stengel A. Effects of microbiome changes on endocrine ghrelin signaling - A systematic review. Peptides 2020;133:170388. [PMID: 32846187 DOI: 10.1016/j.peptides.2020.170388] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
7 Khodaverdi E, Delroba K, Mohammadpour F, Khameneh B, Sajadi Tabassi SA, Tafaghodi M, Kamali H, Hadizadeh F. In-vitro Release Evaluation of Growth Hormone from an Injectable In-Situ Forming Gel Using PCL-PEG-PCL Thermosensitive Triblock. Curr Drug Deliv 2020;17:174-83. [PMID: 31987020 DOI: 10.2174/1567201817666200120120105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Montégut L, Lopez-Otin C, Magnan C, Kroemer G. Old Paradoxes and New Opportunities for Appetite Control in Obesity. Trends Endocrinol Metab 2021;32:264-94. [PMID: 33707095 DOI: 10.1016/j.tem.2021.02.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gimeno RE, Briere DA, Seeley RJ. Leveraging the Gut to Treat Metabolic Disease. Cell Metab 2020;31:679-98. [PMID: 32187525 DOI: 10.1016/j.cmet.2020.02.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
10 Skuratovskaia D, Vulf M, Chasovskikh N, Komar A, Kirienkova E, Shunkin E, Zatolokin P, Litvinova L. The Links of Ghrelin to Incretins, Insulin, Glucagon, and Leptin After Bariatric Surgery. Front Genet 2021;12:612501. [PMID: 33959145 DOI: 10.3389/fgene.2021.612501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Micioni Di Bonaventura E, Botticelli L, Del Bello F, Giorgioni G, Piergentili A, Quaglia W, Cifani C, Micioni Di Bonaventura MV. Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior. Pharmacol Res 2021;172:105847. [PMID: 34438062 DOI: 10.1016/j.phrs.2021.105847] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Torz LJ, Osborne-Lawrence S, Rodriguez J, He Z, Cornejo MP, Mustafá ER, Jin C, Petersen N, Hedegaard MA, Nybo M, Damonte VM, Metzger NP, Mani BK, Williams KW, Raingo J, Perello M, Holst B, Zigman JM. Metabolic insights from a GHSR-A203E mutant mouse model. Mol Metab 2020;39:101004. [PMID: 32339772 DOI: 10.1016/j.molmet.2020.101004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
13 Ricardo-Silgado ML, McRae A, Acosta A. Role of Enteroendocrine Hormones in Appetite and Glycemia. Obes Med 2021;23:100332. [PMID: 34179564 DOI: 10.1016/j.obmed.2021.100332] [Reference Citation Analysis]
14 Giorgioni G, Del Bello F, Quaglia W, Botticelli L, Cifani C, Micioni Di Bonaventura E, Micioni Di Bonaventura MV, Piergentili A. Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor. J Med Chem 2022. [PMID: 35157454 DOI: 10.1021/acs.jmedchem.1c02191] [Reference Citation Analysis]
15 Péraldi-roux S, Bayle M, M'kadmi C, Damian M, Vaillé J, Fernandez G, Paula Cornejo M, Marie J, Banères J, Ben Haj Salah K, Fehrentz J, Cantel S, Perello M, Denoyelle S, Oiry C, Neasta J. Design and Characterization of a Triazole-Based Growth Hormone Secretagogue Receptor Modulator Inhibiting the Glucoregulatory and Feeding Actions of Ghrelin. Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.115114] [Reference Citation Analysis]
16 Vohra MS, Benchoula K, Serpell CJ, Hwa WE. AgRP/NPY and POMC neurons in the arcuate nucleus and their potential role in treatment of obesity. Eur J Pharmacol 2022;915:174611. [PMID: 34798121 DOI: 10.1016/j.ejphar.2021.174611] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]